" class="no-js "lang="en-US"> Next Generation of Surgical Robotics Now Available in the Pacific Northwest - Medtech Alert
Sunday, May 26, 2024

Next Generation of Surgical Robotics Now Available in the Pacific Northwest

Orthopedic surgeons at Northwest Specialty Hospital in Post Falls, Idaho, are among the first in the Pacific Northwest to access the next generation of surgical robotics. The VELYS™ Robotic-Assisted Solution indicated for use with the ATTUNE® Knee System for total knee arthroplasty will soon be one of the few hospitals in the region and the only hospital in North Idaho to offer advanced knee replacement with the VELYS™ solution.

Total knee replacement is a common surgery, with approximately 900,000 primary knee replacements performed annually in the US. Orthopedic surgeons at Northwest Specialty Hospital now have a new option with the VELYS™ Robotic-Assisted Solution, a technology that helps surgeons perform a knee replacement with the use of data that’s tailored to each patient’s anatomy. This technology is designed to help ensure predictable results to improve outcomes, increase mobility and help patients recover faster. Additionally, the VELYS™ Robotic-Assisted Solution works in tandem with the ATTUNE® Knee System, which is an innovative knee implant designed to work more closely with an individual patient’s anatomy. With these systems together, there is now an option for patients seeking the latest technology designed to provide digital precision in knee replacement.

This news follows an announcement by Northwest that the Blue Cross Blue Shield Association had selected Northwest Specialty Hospital as a Blue Distinction Center for Knee and Hip Replacement. This distinction recognizes their expertise in total knee and hip replacement surgeries, resulting in fewer patient complications and readmissions.

Rick Rasmussen, CEO of Northwest Specialty Hospital commented, “The orthopedic surgeons at Northwest Specialty Hospital are committed to bringing our patients the highest quality of care possible by introducing the next-generation of surgical robotics to advance the level of surgical care we offer. This investment builds on the incredible work our team has done to become recognized by Blue Cross for safer knee and hip replacement surgeries.”

Designed by DePuy Synthes, the Orthopedics Company of Johnson & Johnson, the VELYS™ Robotic-Assisted Solution is a first-of-its-kind operating table-mounted solution that adapts to the surgeon’s workflow and utilizes advanced planning capabilities, proprietary technology, and a next-generation design to help surgeons accurately resect bones that align and position the implant relative to the soft-tissue during total knee replacement without the need for pre-operative imaging. The efficient and compact design integrates into any operating room and does so with a much smaller footprint, at less than half the size of other robotic-assisted solutions.

People In This Post

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more